Skip to main content
Erschienen in: Pediatric Radiology 11/2010

01.11.2010 | Original Article

PET assessment of disease activity in children with juvenile idiopathic arthritis

verfasst von: Ukihide Tateishi, Tomoyuki Imagawa, Noriko Kanezawa, Tetsuhiko Okabe, Kazuya Shizukuishi, Tomio Inoue, Shumpei Yokota

Erschienen in: Pediatric Radiology | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The degree of 18-fluorodeoxyglucose (FDG) uptake is previously reported to correlate with physical examination and laboratory tests for evaluating disease activity in patients with rheumatoid arthritis. The clinical validity of 18F-FDG positron emission tomography (PET) has not been evaluated in juvenile idiopathic arthritis (JIA).

Objective

To assess the relationship between 18F-FDG PET uptake and disease activity in children with JIA.

Materials and methods

A total of 560 joints in 28 children (mean age, 5.4 years; range, 1–16 years) with JIA who had undergone whole-body 18F-FDG PET before treatment were retrospectively assessed clinically, biochemically and radiographically. PET images were assessed independently by two readers. We investigated the relationships between the degree of synovial 18F-FDG uptake and radiographic and clinical symptoms and laboratory findings.

Results

Joint tenderness and swelling had a positive association with abnormal 18F-FDG uptake in the joint [odds ratio (OR) 5.37, 7.12, respectively]. The standardized uptake value (SUV) max correlated with the neutrophil count, plasma C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and matrix metalloproteinase (MMP) 3. Joint erosion (OR, 6.17), soft-tissue swelling (OR, 3.77), major joints involvement (OR, 3.50), tenderness (OR, 5.22), and CRP concentration in plasma (OR, 1.81) were positively associated with SUVmax.

Conclusion

The degree of 18F-FDG uptake may be associated with the severity of synovitis in children with JIA.
Literatur
2.
Zurück zum Zitat Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMed Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMed
3.
Zurück zum Zitat Lovell DJ, Giannini EH, Reiff A et al (2000) Etarercept in children with polyarticular rheumatoid arthritis. Paediatric Rheumatology Collaborative Study Group. N Engl J Med 342:763–769CrossRefPubMed Lovell DJ, Giannini EH, Reiff A et al (2000) Etarercept in children with polyarticular rheumatoid arthritis. Paediatric Rheumatology Collaborative Study Group. N Engl J Med 342:763–769CrossRefPubMed
4.
Zurück zum Zitat Russo RA, Katsicas MM, Zalazko M (2002) Etanercept in systemic juvenile idiopathic arthritis. Clin Exp Rheumatol 20:723–726PubMed Russo RA, Katsicas MM, Zalazko M (2002) Etanercept in systemic juvenile idiopathic arthritis. Clin Exp Rheumatol 20:723–726PubMed
5.
Zurück zum Zitat Quartier P, Taupin P, Bourdeaut F et al (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48:1093–1101CrossRefPubMed Quartier P, Taupin P, Bourdeaut F et al (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48:1093–1101CrossRefPubMed
6.
Zurück zum Zitat Gerloni V, Pontikaki I, Gattinara M et al (2005) Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study. Arthritis Rheum 52:548–553CrossRefPubMed Gerloni V, Pontikaki I, Gattinara M et al (2005) Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study. Arthritis Rheum 52:548–553CrossRefPubMed
7.
Zurück zum Zitat Katsicas MM, Russo RA (2005) Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept. Clin Exp Rheumatol 23:545–548PubMed Katsicas MM, Russo RA (2005) Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept. Clin Exp Rheumatol 23:545–548PubMed
8.
Zurück zum Zitat Yokota S, Imagawa T, Miyamae T et al (2004) Long-term therapeutic experience of humanized anti-IL-6 receptor monoclonal antibody (aIL-6R Mab) in systemic-onset juvenile idiopathic arthritis (So-JIA). Arthritis Rheum 50:S438 Yokota S, Imagawa T, Miyamae T et al (2004) Long-term therapeutic experience of humanized anti-IL-6 receptor monoclonal antibody (aIL-6R Mab) in systemic-onset juvenile idiopathic arthritis (So-JIA). Arthritis Rheum 50:S438
9.
Zurück zum Zitat Yokota S, Miyamae T, Imagawa T et al (2005) Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis. Clin Rev Allergy Immunol 28:231–238CrossRefPubMed Yokota S, Miyamae T, Imagawa T et al (2005) Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis. Clin Rev Allergy Immunol 28:231–238CrossRefPubMed
10.
Zurück zum Zitat Yokota S, Imagawa T, Mori M et al (2008) Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomized, double-blind, placebo-controlled, withdrawal phase II trial. Lancet 371:998–1006CrossRefPubMed Yokota S, Imagawa T, Mori M et al (2008) Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomized, double-blind, placebo-controlled, withdrawal phase II trial. Lancet 371:998–1006CrossRefPubMed
11.
Zurück zum Zitat Reed MH, Wilmot DM (1991) The radiology of juvenile rheumatoid arthritis. A review of the English language literature. J Rheumatol Suppl 31:2–22PubMed Reed MH, Wilmot DM (1991) The radiology of juvenile rheumatoid arthritis. A review of the English language literature. J Rheumatol Suppl 31:2–22PubMed
12.
Zurück zum Zitat Rossi F, Di Dia F, Galipo O et al (2006) Use of Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Rheum 55:717–723CrossRefPubMed Rossi F, Di Dia F, Galipo O et al (2006) Use of Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Rheum 55:717–723CrossRefPubMed
13.
Zurück zum Zitat Doria AS, Babyn P, Feldman B (2006) A critical appraisal of radiographic scoring systems for assessment of juvenile idiopathic arthritis. Pediatr Radiol 36:759–772CrossRefPubMed Doria AS, Babyn P, Feldman B (2006) A critical appraisal of radiographic scoring systems for assessment of juvenile idiopathic arthritis. Pediatr Radiol 36:759–772CrossRefPubMed
14.
Zurück zum Zitat Malattia C, Damasio MB, Magnaguagno F et al (2008) Magnetic resonance imaging, ultrasonography, and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis. Arthritis Rheum 59:1764–1772CrossRefPubMed Malattia C, Damasio MB, Magnaguagno F et al (2008) Magnetic resonance imaging, ultrasonography, and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis. Arthritis Rheum 59:1764–1772CrossRefPubMed
15.
Zurück zum Zitat Pedersen TK, Kuseler A, Gelineck J et al (2008) A prospective study of magnetic resonance and radiographic imaging in relation to symptoms and clinical findings of the temporomandibular joint in children with juvenile idiopathic arthritis. J Rheumatol 35:1668–1675PubMed Pedersen TK, Kuseler A, Gelineck J et al (2008) A prospective study of magnetic resonance and radiographic imaging in relation to symptoms and clinical findings of the temporomandibular joint in children with juvenile idiopathic arthritis. J Rheumatol 35:1668–1675PubMed
16.
Zurück zum Zitat Wipke BT, Wang Z, Kim J et al (2002) Dynamic visualization of joint specific autoimmune response through positron emission tomography. Nat Immunol 3:366–372CrossRefPubMed Wipke BT, Wang Z, Kim J et al (2002) Dynamic visualization of joint specific autoimmune response through positron emission tomography. Nat Immunol 3:366–372CrossRefPubMed
17.
Zurück zum Zitat Fonseca A, Wagner J, Yamaga LI et al (2008) (18) F-FDG PET imaging of rheumatoid articular and extraarticular synovitis. J Clin Rheumatol 14:307CrossRefPubMed Fonseca A, Wagner J, Yamaga LI et al (2008) (18) F-FDG PET imaging of rheumatoid articular and extraarticular synovitis. J Clin Rheumatol 14:307CrossRefPubMed
18.
Zurück zum Zitat Beckers C, Ribbens C, André B et al (2004) Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 45:956–964PubMed Beckers C, Ribbens C, André B et al (2004) Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 45:956–964PubMed
19.
Zurück zum Zitat Giannini EH, Ruperto N, Ravelli A et al (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40:1202–1209PubMed Giannini EH, Ruperto N, Ravelli A et al (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40:1202–1209PubMed
20.
Zurück zum Zitat Polisson RP, Schoenberg OI, Fischman A et al (1995) Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum 38:819–825CrossRefPubMed Polisson RP, Schoenberg OI, Fischman A et al (1995) Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum 38:819–825CrossRefPubMed
21.
Zurück zum Zitat Goerres GW, Forster A, Uebelhart D et al (2006) F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Clin Nucl Med 31:386–390CrossRefPubMed Goerres GW, Forster A, Uebelhart D et al (2006) F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Clin Nucl Med 31:386–390CrossRefPubMed
22.
Zurück zum Zitat Elzinga EH, van der Laken CJ, Comans EF et al (2007) 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis. Mol Imaging Biol 9:357–360CrossRefPubMed Elzinga EH, van der Laken CJ, Comans EF et al (2007) 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis. Mol Imaging Biol 9:357–360CrossRefPubMed
23.
Zurück zum Zitat Beckers C, Jeukens X, Ribbens C et al (2006) (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 33:275–280CrossRefPubMed Beckers C, Jeukens X, Ribbens C et al (2006) (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 33:275–280CrossRefPubMed
24.
Zurück zum Zitat Ju JH, Kang KY, Kim IJ et al (2008) Visualization and localization of rheumatoid knee synovitis with FDG-PET/CT images. Clin Rheumatol 27:S39–S41CrossRefPubMed Ju JH, Kang KY, Kim IJ et al (2008) Visualization and localization of rheumatoid knee synovitis with FDG-PET/CT images. Clin Rheumatol 27:S39–S41CrossRefPubMed
25.
Zurück zum Zitat Roivainen A, Parkkola R, Yli-Kerttula T et al (2003) Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum 48:3077–3084CrossRefPubMed Roivainen A, Parkkola R, Yli-Kerttula T et al (2003) Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum 48:3077–3084CrossRefPubMed
Metadaten
Titel
PET assessment of disease activity in children with juvenile idiopathic arthritis
verfasst von
Ukihide Tateishi
Tomoyuki Imagawa
Noriko Kanezawa
Tetsuhiko Okabe
Kazuya Shizukuishi
Tomio Inoue
Shumpei Yokota
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
Pediatric Radiology / Ausgabe 11/2010
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-010-1716-5

Weitere Artikel der Ausgabe 11/2010

Pediatric Radiology 11/2010 Zur Ausgabe

Hermes

Hermes

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.